This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (6)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Joe L. Koch, MD

Arch Intern Med. 1967;119(3):305-306.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

THE GRAVE prognosis associated with aplastic anemia is well established and has been repeatedly documented.^1-3 Various regimens have been explored in the management of this disease. These include either alone or in combinations, adrenocorticosteroids, androgens, and splenectomy.^{2,4 6} Varying degrees of success have been reported and a number of remissions have been reported.^4-6 Despite these experiences, spontaneous remission has been the elusive goal of all treatment programs. In 1962 and in 1965, Lewis described a hemolytic component which may be present in aplastic anemia and reported the possible beneficial effects of splenectomy; however, in none of his cases were radioisotope studies used for the detection of splenic sequestration prior to splenectomy.^3,7 In 1965, Ingall et al reported that phenylalanine mitigated certain toxic effects induced by chloramphenicol.⁸ It is the purpose of this report to describe a patient with aplastic anemia, who exhibited a partial remission following splenectomy.

Report of Case . . . [Full Text PDF of this Article]

Author Affiliations
Beaumont, Tex

From the Baptist Hospital of Southeast Texas, Beaumont.

Footnotes
Received for publication Aug 18, 1966; accepted Oct 24.

Reprint requests to Medical Record Library, Baptist Hospital of Southeast Texas, PO Drawer 1591, Beaumont, Tex 77701 (Dr. Koch).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?